p53 mutation and MDM2 amplification frequency pediatric rhabdomyosarcoma tumors and cell lines Academic Article Article uri icon

Overview

MeSH Major

  • Philadelphia Chromosome
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma

abstract

  • p53 mutation and MDM2 gene amplification frequencies are extremely low in RMS tumors, but a wild-type p53 genotype is not always associated with a favorable prognosis.

publication date

  • August 26, 2000

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1002/1096-911X(200008)35:2<96::AID-MPO2>3.0.CO;2-Z

PubMed ID

  • 10918230

Additional Document Info

start page

  • 96

end page

  • 103

volume

  • 35

number

  • 2